Humana (HUM) Gains As Market Dips: What You Should Know

10:15pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) closed at $499.79 in the latest trading session, marking a +0.51% move from the prior day.

Cigna's (CI) Arm Adds Five Digital Health Apps to Its Platform

08:28pm, Friday, 16'th Sep 2022 Zacks Investment Research
Cigna's (CI) unit bolsters its clinical platform Digital Health Formulary by including five on-line solutions, aiming to relieve people from chronic medical conditions.

8 Analysts Have This to Say About Humana

04:35pm, Friday, 16'th Sep 2022 Benzinga
Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 3 0 0 Last 30D 0 1 1 0
Oppenheimer has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $520.00 to $550.00. Shares of Humana are trading down 0.25% over the last 24 hours, at $4

Humana (HUM) Surges 8.4%: Is This an Indication of Further Gains?

03:23pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th

Is Humana (HUM) Stock Undervalued Right Now?

01:40pm, Friday, 16'th Sep 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Company News for Sep 16, 2022

01:40pm, Friday, 16'th Sep 2022 Zacks Investment Research
Companies in The News Are: MSFT, HUM, CTRA, ADBE
Raymond James raised the price target for HCA Healthcare, Inc. (NYSE: HCA) from $230 to $250. HCA Healthcare shares rose 0.4% to close at $208.97 on Thursday. Oppenheimer boosted the price target on
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th

Humana (HUM) Hikes Guidance: Here's Why It's a Good Sign

12:13pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.

Is Humana (HUM) Stock Undervalued Right Now?

11:17am, Friday, 16'th Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of

Dow finishes nearly 200 points lower as Treasury yields rise

08:32pm, Thursday, 15'th Sep 2022 MarketWatch
U.S. stocks finished lower as bond yields rose further Thursday ahead of a likely Federal Reserve interest rate rise next week.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE